VITAL INNOVATIONS HOLDINGS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2 HKD | -0.99% |
|
-8.68% | -25.93% |
| 20/05 | Vital Innovations Widens Loss in 2023 | MT |
| 16/05 | Vital Innovations Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Capitalization 1 | 492.6 | 269.7 | 336.2 | 200.9 | 177.2 | 208.6 |
| Enterprise Value (EV) 1 | -205.5 | 241 | 303 | 189.6 | 148.6 | 218.2 |
| P/E ratio | 33.9 x | -48.1 x | -3.44 x | -9.8 x | -10.1 x | -10 x |
| Yield | - | - | - | - | - | - |
| Capitalization / Revenue | 0.54 x | 0.33 x | 0.38 x | 0.3 x | 0.16 x | 0.25 x |
| EV / Revenue | -0.23 x | 0.3 x | 0.34 x | 0.28 x | 0.14 x | 0.26 x |
| EV / EBITDA | 15.9 x | -14.9 x | -2.98 x | -8.58 x | -8.43 x | -11.2 x |
| EV / FCF | 14.6 x | -0.4 x | 7.83 x | -15.5 x | 6.37 x | -7.16 x |
| FCF Yield | 6.86% | -247% | 12.8% | -6.46% | 15.7% | -14% |
| Price to Book | 0.67 x | 0.41 x | 0.6 x | 0.37 x | 0.34 x | 0.41 x |
| Nbr of stocks (in thousands) | 8,50,000 | 8,50,000 | 8,50,000 | 8,50,000 | 8,50,000 | 8,50,000 |
| Reference price 2 | 0.5795 | 0.3173 | 0.3956 | 0.2363 | 0.2084 | 0.2454 |
| Announcement Date | 29/04/19 | 09/07/20 | 28/04/21 | 28/04/22 | 26/04/23 | 30/05/24 |
1CNY in Million2CNY
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net sales 1 | 911.4 | 815.9 | 881.1 | 672.7 | 1,092 | 835.6 |
| EBITDA 1 | -12.93 | -16.14 | -101.7 | -22.08 | -17.62 | -19.45 |
| EBIT 1 | -13 | -16.17 | -101.7 | -22.11 | -17.64 | -19.45 |
| Operating Margin | -1.43% | -1.98% | -11.55% | -3.29% | -1.62% | -2.33% |
| Earnings before Tax (EBT) 1 | 14.55 | -5.574 | -97.61 | -20.57 | -17.56 | -20.85 |
| Net income 1 | 14.55 | -5.574 | -97.62 | -20.5 | -17.55 | -20.84 |
| Net margin | 1.6% | -0.68% | -11.08% | -3.05% | -1.61% | -2.49% |
| EPS 2 | 0.0171 | -0.006600 | -0.1149 | -0.0241 | -0.0206 | -0.0245 |
| Free Cash Flow 1 | -14.1 | -596.2 | 38.7 | -12.25 | 23.32 | -30.48 |
| FCF margin | -1.55% | -73.07% | 4.39% | -1.82% | 2.13% | -3.65% |
| FCF Conversion (EBITDA) | - | - | - | - | - | - |
| FCF Conversion (Net income) | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - |
| Announcement Date | 29/04/19 | 09/07/20 | 28/04/21 | 28/04/22 | 26/04/23 | 30/05/24 |
1CNY in Million2CNY
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | 9.65 |
| Net Cash position 1 | 698 | 28.7 | 33.2 | 11.3 | 28.6 | - |
| Leverage (Debt/EBITDA) | - | - | - | - | - | -0.496 x |
| Free Cash Flow 1 | -14.1 | -596 | 38.7 | -12.2 | 23.3 | -30.5 |
| ROE (net income / shareholders' equity) | 1.98% | -0.8% | -16% | -3.73% | -3.29% | -4.06% |
| ROA (Net income/ Total Assets) | -0.9% | -1.24% | -8.7% | -2.05% | -1.75% | -1.95% |
| Assets 1 | -1,609 | 450 | 1,122 | 1,002 | 1,003 | 1,071 |
| Book Value Per Share 2 | 0.8700 | 0.7800 | 0.6600 | 0.6400 | 0.6200 | 0.5900 |
| Cash Flow per Share 2 | 0.0300 | 0.0600 | 0.0600 | 0.0300 | 0.0400 | 0.0300 |
| Capex 1 | 0.01 | - | - | - | 0.01 | 0.01 |
| Capex / Sales | 0% | - | - | - | 0% | 0% |
| Announcement Date | 29/04/19 | 09/07/20 | 28/04/21 | 28/04/22 | 26/04/23 | 30/05/24 |
1CNY in Million2CNY
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
| 1st Jan change | Capi. | |
|---|---|---|
| -25.93% | 22M | |
| +2.69% | 1.64B | |
| -4.00% | 1.23B | |
| +135.02% | 1.15B | |
| +15.53% | 868M | |
| -14.00% | 719M | |
| +47.77% | 688M | |
| -34.93% | 332M | |
| +0.31% | 319M | |
| +9.23% | 90.03M |
- Stock Market
- Equities
- 6133 Stock
- Financials Vital Innovations Holdings Limited
